文献速递心血管MR

心脏磁共振在缺血性心肌病预防性ICD治疗中的应用:DERIVATE-ICM国际注册研究

Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry.
PubMed 文献 · JACC Cardiovasc Imaging · 2023-05-24

DERIVATE-ICM国际多中心注册研究纳入861例缺血性心肌病合并慢性心衰且TTE-LVEF<50%的患者,评估CMR相较TTE对ICD植入指征的净重分类改善。中位随访1054天,10.2%发生MAACE;CMR-LVEF、LGE质量及左室舒张末期容积指数为独立预测因子,多参数CMR加权预测评分较TTE-LVEF 35%阈值的NRI为31.7%(P=0.007)。

要点

  • CMR-LVEF、LGE质量与左室舒张末期容积指数是缺血性心肌病患者MAACE的独立预测因子。
  • 多参数CMR加权预测评分较TTE-LVEF 35%阈值对MAACE风险分层NRI达31.7%。
  • 对TTE-LVEF<50%的缺血性心肌病患者,CMR可辅助优化预防性ICD植入指征。

局限性

  • 原文未明确列出研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Implantable cardioverter-defibrillator (ICD) therapy is the most effective prophylactic strategy against sudden cardiac death (SCD) in patients with ischemic cardiomyopathy (ICM) and left ventricle ejection fraction (LVEF) ≤35% as detected by transthoracic echocardiograpgy (TTE). This approach has been recently questioned because of the low rate of ICD interventions in patients who received implantation and the not-negligible percentage of patients who experienced SCD despite not fulfilling criteria for implantation.

OBJECTIVES: The DERIVATE-ICM registry (CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy; NCT03352648) is an international, multicenter, and multivendor study to assess the net reclassification improvement (NRI) for the indication of ICD implantation by the use of cardiac magnetic resonance (CMR) as compared to TTE in patients with ICM.

METHODS: A total of 861 patients with ICM (mean age 65 ± 11 years, 86% male) with chronic heart failure and TTE-LVEF <50% participated. Major adverse arrhythmic cardiac events (MAACE) were the primary endpoints.

RESULTS: During a median follow-up of 1,054 days, MAACE occurred in 88 (10.2%). Left ventricular end-diastolic volume index (HR: 1.007 [95% CI: 1.000-1.011]; P = 0.05), CMR-LVEF (HR: 0.972 [95% CI: 0.945-0.999]; P = 0.045) and late gadolinium enhancement (LGE) mass (HR: 1.010 [95% CI: 1.002-1.018]; P = 0.015) were independent predictors of MAACE. A multiparametric CMR weighted predictive derived score identifies subjects at high risk for MAACE compared with TTE-LVEF cutoff of 35% with a NRI of 31.7% (P = 0.007).

CONCLUSIONS: The DERIVATE-ICM registry is a large multicenter registry showing the additional value of CMR to stratify the risk for MAACE in a large cohort of patients with ICM compared with standard of care.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Pontone, Guaricci, Fusini, et al. Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry. JACC Cardiovasc Imaging. 2023. PMID: 37227329. doi:10.1016/j.jcmg.2023.03.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。